Bio-Techne Corp’s filing revealed that its Director Herr Amy E. unloaded Company’s shares for reported $0.12 million on Feb 14 ’25. In the deal valued at $65.96 per share,1,860 shares were sold. As a result of this transaction, Herr Amy E. now holds 1,976 shares worth roughly $ 0.13 million.
Then, JOSHUA MOLHO bought 1,860 shares, generating $122,691 in total proceeds.
Before that, Kelderman Kim sold 13,392 shares. Bio-Techne Corp shares valued at $1,035,013 were divested by the Chief Executive Officer at a price of $77.29 per share. As a result of the transaction, Kelderman Kim now holds 39,004 shares, worth roughly $2.55 million.
Citigroup downgraded its Bio-Techne Corp [TECH] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early February with a ‘”a Sector outperform”‘ rating. Stifel also remained covering TECH and has decreased its forecast on February 02, 2024 with a “Hold” recommendation from previously “Buy” rating. UBS started covering the stock on December 07, 2023. It rated TECH as “a Buy”.
Price Performance Review of TECH
On Tuesday, Bio-Techne Corp [NASDAQ:TECH] saw its stock fall -0.99% to $65.29. Over the last five days, the stock has lost -6.62%. Bio-Techne Corp shares have fallen nearly -9.36% since the year began. Nevertheless, the stocks have fallen -6.89% over the past one year. While a 52-week high of $85.57 was reached on 02/05/25, a 52-week low of $61.16 was recorded on 02/18/25. SMA at 50 days reached $73.69, while 200 days put it at $74.86.
Levels Of Support And Resistance For TECH Stock
The 24-hour chart illustrates a support level at 64.25, which if violated will result in even more drops to 63.20. On the upside, there is a resistance level at 66.50. A further resistance level may holdings at 67.70. The Relative Strength Index (RSI) on the 14-day chart is 29.59, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.68, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.08%. Stochastics %K at 2.91% indicates the stock is a buying.
The most recent change occurred on August 28, 2023 when William Blair began covering the stock and recommended ‘”an Outperform”‘ rating .
